发行结构与机构
港股 IPO 发行结构与参与机构：甲乙组、内地参与、基石、保荐人、承销团与绿鞋。
甲尾（A组最后一档）期望中签手数勉强超过或低于乙头（B组第一档）的股票。差距比越低，档位结构越反常。
有基石投资者的IPO是否表现更好？对比有/无基石投资者IPO的平均首日回报、胜率和认购水平。气泡大小=首日回报幅度, 绿色=正, 红色=负。
| 行业 | 有基石数量 | 有基石回报 | 无基石数量 | 无基石回报 |
|---|---|---|---|---|
| 3D打印/消费电子/智能制造 | 1 | 21.28% | 0 | — |
| CCUS | 0 | — | 1 | 44.25% |
| Other | 188 | 9.79% | 58 | 3.47% |
| 人工智能 | 12 | 88.71% | 9 | 143.11% |
| 企业服务/软件 | 8 | 21.67% | 0 | — |
| 储能电池 | 2 | 31.29% | 0 | — |
| 光电互连 | 1 | 44.74% | 0 | — |
| 光通信 | 1 | 4.61% | 0 | — |
| 其他零售商 | 0 | — | 1 | -45.75% |
| 冷链物流 | 2 | 0.33% | 0 | — |
| 化工新材料 | 2 | 7.79% | 0 | — |
| 医疗健康 | 9 | 29.79% | 5 | 91.04% |
哪些基石投资者能持续选中表现优异的IPO？按所投股票的首日平均回报排序，展示参与≥5笔交易的基石投资者战绩。气泡大小 = 累计投资金额。
| # | 投资者 | 交易数 | 平均回报 | 胜率 | 最佳交易 | 最差交易 | 累计投资 (港元等值) |
|---|---|---|---|---|---|---|---|
| 1 | GIC | 5 | +153.14% | 40.0% | 01879 (+383.62%) | 02475 (-1.55%) | 18.3B |
| 2 | Aspex | 6 | +151.39% | 83.3% | 01879 (+383.62%) | 03308 (-2.04%) | 18.5B |
| 3 | Schroders | 6 | +141.03% | 100.0% | 01879 (+383.62%) | 03200 (+14.82%) | 2.6B |
| 4 | 淡马锡 | 8 | +102.74% | 87.5% | 01879 (+383.62%) | 03757 (-4.95%) | 17.9B |
| 5 | 工银理财 | 14 | +90.5% | 92.9% | 01879 (+383.62%) | 01081 (+0.0%) | 2.5B |
| 6 | 加皇环球资产管理(亚洲)有限公司 | 5 | +77.82% | 100.0% | 06606 (+215.08%) | 02137 (+3.15%) | 11.4B |
| 7 | 富国基金 | 10 | +77.05% | 90.0% | 03858 (+177.84%) | 01081 (+0.0%) | 2.3B |
| 8 | 富国基金管理有限公司 | 12 | +76.85% | 100.0% | 09606 (+116.7%) | 01758 (+21.61%) | 9.1B |
| 9 | 富国资产管理(香港)有限公司 | 14 | +76.43% | 100.0% | 09606 (+116.7%) | 02788 (+32.76%) | 8.8B |
| 10 | Eastspring | 5 | +73.65% | 80.0% | 00100 (+109.09%) | 02475 (-1.55%) | 6.0B |
| 11 | 汇添富基金管理股份有限公司 | 11 | +73.53% | 81.8% | 02155 (+258.87%) | 06669 (-26.05%) | 15.9B |
| 12 | TruMed | 11 | +70.93% | 100.0% | 09606 (+116.7%) | 06990 (+3.14%) | 9.8B |
| 13 | 广发基金 | 12 | +66.04% | 91.7% | 03858 (+177.84%) | 06880 (+0.0%) | 12.5B |
| 14 | Mirae Asset Securities Co., Ltd. | 6 | +64.68% | 66.7% | 00068 (+144.09%) | 02050 (-0.13%) | 6.3B |
| 15 | Huadeng Technology | 9 | +64.05% | 77.8% | 07666 (+126.67%) | 03308 (-2.04%) | 7.0B |
| 16 | Invesco Advisers, Inc. | 7 | +62.9% | 71.4% | 06606 (+215.08%) | 02268 (-2.3%) | 48.6B |
| 17 | 易方达基金管理有限公司 | 12 | +60.93% | 83.3% | 09606 (+116.7%) | 06669 (-26.05%) | 13.7B |
| 18 | Cormorant Asset Management, LP | 10 | +60.73% | 100.0% | 06606 (+215.08%) | 06996 (+1.11%) | 10.0B |
| 19 | Rock Springs Capital Master Fund LP | 8 | +60.67% | 75.0% | 06606 (+215.08%) | 02126 (-7.56%) | 6.0B |
| 20 | Prime Capital Funds | 5 | +60.35% | 100.0% | 06969 (+150.0%) | 01801 (+18.6%) | 12.7B |
| 21 | Boyu | 5 | +59.61% | 60.0% | 00100 (+109.09%) | 00625 (-0.12%) | 1176.6B |
| 22 | 富国香港 | 9 | +59.2% | 100.0% | 03858 (+177.84%) | 02768 (+4.03%) | 6022万 |
| 23 | 正心谷资本 | 6 | +59.17% | 100.0% | 09887 (+91.71%) | 02657 (+9.3%) | 6.7B |
| 24 | Fidelity International | 18 | +59.08% | 100.0% | 01024 (+160.87%) | 06996 (+1.11%) | 85.1B |
| 25 | Worldwide Healthcare Trust PLC | 6 | +58.79% | 100.0% | 06606 (+215.08%) | 01521 (+4.69%) | 11.3B |
| 26 | 3W Fund | 17 | +57.84% | 82.4% | 01879 (+383.62%) | 01688 (-4.62%) | 11.6B |
| 27 | LAV Amber Limited | 5 | +56.2% | 60.0% | 06606 (+215.08%) | 06628 (-17.25%) | 6.4B |
| 28 | HHLR Advisors, Ltd. | 8 | +55.7% | 100.0% | 06656 (+103.42%) | 09981 (+2.94%) | 9.2B |
| 29 | Perseverance Asset Management International (Singapore) Pte. Ltd. | 9 | +53.7% | 88.9% | 06656 (+103.42%) | 06669 (-26.05%) | 24.6B |
| 30 | BlackRock Funds | 18 | +52.6% | 83.3% | 01024 (+160.87%) | 02142 (-10.99%) | 97.9B |
仅分析参与≥5笔交易的基石投资者。投资金额以港元等值计（美元按~7.8换算）。基石投资者的过往业绩不代表未来IPO表现。
哪些IPO保荐人能持续带来表现优异的IPO？按保荐项目的首日平均回报排序，展示参与≥5笔交易的保荐人战绩。气泡大小 = 交易数量。绿色 = 正平均回报，红色 = 负平均回报。
| # | 保荐人 | 交易数 | 独家保荐 | 联席保荐 | 平均回报 | 胜率 | 最佳项目 | 最差项目 |
|---|---|---|---|---|---|---|---|---|
| 1 | 上银国际有限公司 | 5 | 4 | 1 | +814.41% | 80.0% | 08091 (+2937.04%) | 01612 (-6.0%) |
| 2 | 新源资本有限公司 | 5 | 4 | 1 | +494.63% | 80.0% | 08149 (+1170.59%) | 08547 (+0.0%) |
| 3 | 大有融资有限公司 | 24 | 24 | 0 | +434.56% | 87.5% | 08369 (+1900.0%) | 02682 (-44.0%) |
| 4 | 东皓资本有限公司 | 5 | 5 | 0 | +417.99% | 100.0% | 08411 (+2005.0%) | 08392 (+11.36%) |
| 5 | 天财资本国际有限公司 | 11 | 11 | 0 | +375.54% | 90.9% | 08182 (+1525.0%) | 08417 (-2.94%) |
| 6 | 浩德融资有限公司 | 16 | 15 | 1 | +242.73% | 75.0% | 08097 (+1556.0%) | 01346 (-27.06%) |
| 7 | 络绎资本有限公司 | 7 | 6 | 1 | +217.23% | 85.7% | 08432 (+1296.55%) | 08523 (-20.0%) |
| 8 | 丰盛融资有限公司 | 41 | 40 | 1 | +205.8% | 82.9% | 08221 (+2033.33%) | 01660 (-22.5%) |
| 9 | 建泉融资有限公司 | 11 | 11 | 0 | +190.58% | 63.6% | 08290 (+2100.0%) | 06822 (-24.64%) |
| 10 | 华富建业企业融资有限公司 | 18 | 17 | 1 | +174.98% | 94.4% | 08245 (+1145.61%) | 01522 (-27.0%) |
| 11 | 富比资本有限公司 | 16 | 16 | 0 | +106.13% | 68.8% | 08240 (+1500.0%) | 08096 (-32.14%) |
| 12 | 派杰亚洲有限公司 | 18 | 15 | 3 | +95.08% | 61.1% | 08300 (+1166.67%) | 08511 (-23.85%) |
| 13 | 汇富融资有限公司 | 30 | 29 | 1 | +71.83% | 66.7% | 08133 (+965.0%) | 02187 (-29.33%) |
| 14 | 凯基金融亚洲有限公司 | 7 | 7 | 0 | +71.13% | 85.7% | 08349 (+388.57%) | 08353 (-18.92%) |
| 15 | 中国光大融资有限公司 | 40 | 32 | 8 | +67.41% | 62.5% | 08052 (+1900.0%) | 02450 (-44.5%) |
| 16 | 兴业金融融资有限公司 | 11 | 11 | 0 | +61.23% | 54.5% | 08346 (+428.3%) | 01235 (-25.4%) |
| 17 | 创升融资有限公司 | 34 | 30 | 4 | +59.97% | 67.6% | 08057 (+726.67%) | 02680 (-45.56%) |
| 18 | 铠盛资本有限公司 | 14 | 9 | 5 | +59.58% | 64.3% | 08093 (+496.36%) | 00331 (-25.09%) |
| 19 | 力高企业融资有限公司 | 25 | 23 | 2 | +57.38% | 60.0% | 08035 (+851.22%) | 03938 (-36.31%) |
| 20 | 民银资本有限公司 | 23 | 14 | 9 | +53.82% | 73.9% | 02672 (+367.95%) | 06918 (-34.78%) |
| 21 | 创侨国际有限公司 | 13 | 12 | 1 | +51.84% | 69.2% | 08121 (+300.0%) | 02448 (-17.5%) |
| 22 | 同人融资有限公司 | 23 | 23 | 0 | +45.05% | 73.9% | 08549 (+330.0%) | 01692 (-33.85%) |
| 23 | 域高融资有限公司 | 11 | 11 | 0 | +42.82% | 72.7% | 08027 (+170.0%) | 02263 (-20.0%) |
| 24 | 西证(香港)融资有限公司 | 14 | 14 | 0 | +42.68% | 71.4% | 02427 (+230.19%) | 01545 (-10.0%) |
| 25 | 德健融资有限公司 | 24 | 24 | 0 | +41.36% | 79.2% | 08321 (+700.0%) | 01937 (-36.79%) |
| 26 | 八方金融有限公司 | 7 | 6 | 1 | +39.82% | 85.7% | 01711 (+185.71%) | 01536 (-8.7%) |
| 27 | 国泰君安融资有限公司 | 103 | 62 | 41 | +37.76% | 67.0% | 08127 (+966.67%) | 02230 (-31.11%) |
| 28 | 浦银国际融资有限公司 | 13 | 5 | 8 | +34.97% | 61.5% | 01384 (+150.56%) | 02512 (-17.39%) |
| 29 | 富瑞金融集团香港有限公司 | 19 | 2 | 17 | +31.13% | 52.6% | 07666 (+126.67%) | 01228 (-26.93%) |
| 30 | 中银国际亚洲有限公司 | 53 | 20 | 33 | +27.97% | 60.4% | 02672 (+367.95%) | 01809 (-25.64%) |
仅分析参与≥5笔保荐交易的保荐人。独家保荐 = 唯一保荐人；联席保荐 = 多家保荐人之一。IPO保荐人负责尽职调查并将公司推向市场。保荐人过往业绩不代表未来IPO表现。
承销团银行越多，IPO首日表现越好还是越差？分析总承销团规模、牵头经办人数量、账簿管理人数量与平均首日回报的关系。结果出人意料：小承销团的IPO表现持续优于大承销团。
| 承销团规模 | IPO数量 | 平均回报 | 中位回报 | 胜率 |
|---|---|---|---|---|
| 1-2 | 333 | +109.74% | +5.67% | 70.6% |
| 3-5 | 585 | +56.91% | +3.45% | 60.9% |
| 6-10 | 418 | +15.33% | +0.38% | 52.4% |
| 11-20 | 373 | +19.0% | +1.89% | 58.4% |
| 21+ | 78 | +34.94% | +3.48% | 65.4% |
| 承销团规模 | IPO数量 | 平均回报 | 中位回报 | 胜率 |
|---|---|---|---|---|
| 1-2 | 504 | +100.86% | +5.69% | 69.0% |
| 3-5 | 444 | +43.96% | +2.5% | 58.3% |
| 6-10 | 392 | +12.94% | +0.69% | 53.8% |
| 11-20 | 270 | +19.42% | +1.57% | 56.7% |
| 21+ | 118 | +18.2% | +1.08% | 60.2% |
| 承销团规模 | IPO数量 | 平均回报 | 中位回报 | 胜率 |
|---|---|---|---|---|
| 1-2 | 663 | +86.58% | +5.38% | 68.5% |
| 3-5 | 411 | +18.92% | +0.64% | 52.3% |
| 6-10 | 340 | +12.27% | +0.62% | 54.1% |
| 11-20 | 239 | +20.54% | +1.89% | 57.3% |
| 21+ | 91 | +18.44% | +0.95% | 59.3% |
承销团 = 参与IPO交易的所有银行/金融机构。牵头经办人负责分销，账簿管理人负责订单簿和定价。规模与回报的反向关系可能源于：大承销团 = 大型IPO = 定价充分、上涨空间有限；小承销团 = 小盘IPO = 首日弹性更大。过往规律不代表未来表现。
超额配股权允许承销商额外发售最多15%股份，用于价格稳定。有超额配股权的IPO首日表现有何不同？原始回报对比易受市值规模效应混淆，需按市值调整后判断。
| 指标 | 有超额配股权 | 无超额配股权 | 差距 |
|---|---|---|---|
| IPO数量 | 213 | 217 | -4 |
| 平均回报 | 37.07% | 39.99% | -2.9% |
| 中位回报 | 7.5% | 13.65% | -6.2% |
| 胜率 | 66.2% | 71.4% | -5.2% |
| 波动率 | 76.99% | 72.2% | +4.8% |
| 平均超购 | 1495.0x | 1944.0x | -449.0x |
| 市值区间 | 有超额配股权 (#) | 有超额配股权 (%) | 无超额配股权 (#) | 无超额配股权 (%) | Spread |
|---|---|---|---|---|---|
| 小盘 (<20亿) | 9 | -2.3% | 10 | 129.4% | -131.7pp |
| 中盘 (20-100亿) | 44 | 95.2% | 55 | 62.7% | +32.5pp |
| 大盘 (100-500亿) | 64 | 30.7% | 29 | 60.4% | -29.7pp |
| 超大盘 (>500亿) | 33 | 31.2% | 2 | 22.6% | +8.6pp |
超额配股权（Greenshoe/Over-allotment Option）由发行人授予承销商，允许其在上市后30天内按发行价额外购买最多15%的股份。其双重作用：(1) 价格稳定——承销商可在股价下跌时买入支撑；(2) 满足超额需求。有超额配股权的IPO多为大规模项目，因此原始回报对比被规模效应严重混淆。过往规律不代表未来表现。
本页分析港股 IPO 的发行结构与参与机构：甲乙组尾部/头部差距、内地参与率、基石投资者与保荐人的历史战绩、承销团规模与绿鞋机制的影响。数据来源于港交所上市文件与配发结果公告。
